Overview
The DIA Global QPPV Forum is a must-attend conference for anyone involved in pharmacovigilance. With a focus on the most pressing issues facing the industry today, this year's topics include global QPPV challenges, trends requiring QPPV awareness, and the impact of modern technology on the field. In addition, we will continue our popular 'QPPV talks' - quick, inpirational sessions that provide practical insight into real-world cases.
With input from regulators and industry leaders from around the world, this conference promises to provide valuable insights into the most pressing issues facing QPPVs today - and don't forget our 'Hot Topics' session!
So join us at the DIA Global QPPV Forum to network with peers, gain valuable insights, and stay ahead of the curve in the ever-evolving role.
Why should you attend this conference?
Featured
Short Course or Primer
-
Nov 07, 2023
Pre-conference Workshop 1: Introduction to the Role of QPPVs
Learn more -
Nov 07, 2023
Pre-conference Workshop 2: Globalisation of PSMF
Learn more
Who should attend?
- Global QPPVs/ Deputies
- Regulators
- Pharmacovigilance Consultants
- Directors of Pharmacovigilance Oversight and Standards
- Drug Safety Managers/Leaders
- Auditors
- Medical and Regulatory Affairs Experts
- Aspiring PV Specialists/QPPVs
Program Committee
-
Gemma Jimenez Sese • Patient Safety Director, EU QPPV
Almirall, S.A., Spain -
Magnus Ysander, MD • EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden -
Angela Van Der Salm, PhD, MSc • Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Shahinaz Badr • Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Vicki Edwards, RPh • Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Maarten Lagendijk, MSc • Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN • Director
Castle Pharmacovigilance Ltd, United Kingdom -
Katarzyna Swiderek, MPharm, RPh • Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc • Principal Quality Lead, PDQ Quality Assurance Process GVP
Roche, United Kingdom -
Claire Longman, MSc • Expert Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Willemijn van der Spuij, MSc • Executive Director, WorldWide Patient Safety International, Europe
Switzerland